Products
Services
Resources
Selection Guides
About
Activin receptor type-1 Inhibitors (IC50, Ki)
Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
 | 4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | IC50 | 3.26 [1], 17.0 [2], 40.7 [3] |
 | 4-[6-(4-Propan-2-yloxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | IC50 | 100.0 [1], 107.9 [2] |
 | Dorsomorphin | IC50 | 67.5 [1], 148.1 [2] |
 | 1-(4-(6-Methyl-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl)phenyl)piperazine | IC50 | 24.0 [1], 27.0 [2] |
 | (4S,9S,10S)-9,10,18-Trihydroxy-16-methoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-triene-2,8-dione | IC50 | 217.0 [1], 3353.0 [2] |
References
This online resource may be cited as follows
MLA | "Quest Database™ Activin receptor type-1 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 16 Jun. 2026, https://www.aatbio.com/data-sets/activin-receptor-type-1-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, June 16). Quest Database™ Activin receptor type-1 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/activin-receptor-type-1-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |